Pliant Therapeutics, Inc.
PLRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $797 | $1,063 | $812 | $484 |
| - Cash | $71 | $63 | $34 | $52 |
| + Debt | $60 | $11 | $16 | $7 |
| Enterprise Value | $786 | $1,012 | $794 | $439 |
| Revenue | $0 | $2 | $10 | $8 |
| % Growth | -100% | -83.7% | 27.9% | – |
| Gross Profit | $0 | $2 | $10 | $8 |
| % Margin | – | 100% | 100% | 100% |
| EBITDA | -$205 | -$158 | -$119 | -$96 |
| % Margin | – | -10,014.4% | -1,227.1% | -1,264.2% |
| Net Income | -$210 | -$161 | -$123 | -$97 |
| % Margin | – | -10,211.1% | -1,273.3% | -1,284.5% |
| EPS Diluted | -3.47 | -2.75 | -2.94 | -2.71 |
| % Growth | -26.2% | 6.5% | -8.5% | – |
| Operating Cash Flow | -$156 | -$116 | -$95 | -$75 |
| Capital Expenditures | -$4 | -$1 | -$2 | -$2 |
| Free Cash Flow | -$159 | -$117 | -$96 | -$77 |